2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol,
Atarax,
Durrax,
Hydroxyzine,
Hydroxyzine Dihydrochloride,
Hydroxyzine Hydrochloride,
Hydroxyzine Pamoate,
Orgatrax,
Pamoate, Hydroxyzine,
Vistaril,
Hydroxyzine dihydrochloride,
2192-20-3,
Hydroxyzine 2HCl,
Hydroxyzine hydrochloride,
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol dihydrochloride,
Hydroxyzine Hcl,
Arcanax,
Neurolax,
Vistaject,
Vistarex,
Vistazine,
Alamon,
Disron,
Quiess,
Marax,
Atranine A,
Vistaril steraject,
Vistaril Parenteral,
Hydroxyzine (dihydrochloride),
Durrax,
Tran-Q dihydrochloride,
Ataraxoid dihydrochloride,
MFCD00058200,
Tranquizine dihydrochloride,
EINECS 218-586-3,
AK-54930,
AI3-50162,
W-107513,
CHEBI:5819,
(+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride,
2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride,
Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine [French],
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride,
Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, dihydrochloride,
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-,
QYS,
hydroxyzine-2hcl,
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride,
Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride,
Hydroxyzine DiHCl,
Vistaril (TN),
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, hydrochloride (1:2),
Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2),
Prestwick_272,
Atarax (TN),
Atarax dihydrochloride,
AC1Q3ADT,
HYDROXIZINE CHLORIDE,
Hydroxyzine(dihydrochloride),
AC1L3M8D,
Hydroxyzine Hydrochloride,(S),
SCHEMBL491323,
C21H27ClN2O2.2HCl,
C21H29Cl3N2O2,
CHEMBL3186993,
DTXSID2040737,
CTK8B4497,
HY-B0548A,
Hydroxyzine hydrochloride [USAN],
ANOMHKZSQFYSBR-UHFFFAOYSA-N,
HMS1568K08,
BCP08800,
Hydroxyzine dihydrochloride, >=98%,
ANW-45296,
Hydroxyzine hydrochloride [USP:JAN],
s4026,
AKOS015846478,
Hydroxyzine hydrochloride (JP17/USP),
AC-8086,
AN-8376,
API0002955,
CCG-220133,
CS-2651,
HS-0097,
2-(2-{4-[(4-chlorphenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethanoldihydrochlorid,
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride,
KS-00001F80,
NCGC00089816-02,
BC204943,
H965,
LS-66602,
AB0005753,
AX8032687,
ST2403814,
TC-063555,
FT-0658716,
SW196577-3,
VU0239818-5,
D00672,
192H203,
SR-01000003137,
SR-01000003137-2,
Hydroxyzine Hydrochloride 1.0 mg/ml in Methanol (as free base),
Hydroxyzine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
(+/-)-2-(2-{4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl}ethoxy)ethanol hydrochloride,
2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol dihydrochloride,
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol 2HCl,
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride,
Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine,
Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,dihydrochloride,
Hydroxyzine Dihydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Hydroxyzine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Hydroxyzine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
Orgatrax,
Atarax,
hydroxyzine,
Paxistil,
Vistaril,
Atazina,
Aterax,
Mixture Name,
CID91513,
AR-1C6498,
UNII-76755771U3,
Hydroxyzine dihydrochloride, 98% - 10G 10g,
76755771U3,
163837-38-5,
2243-80-3,